Issue: March 2018
March 08, 2018
1 min read
Save

Trial Scorecard: DECREASE-PCI

Issue: March 2018
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Analysis of the safety and efficacy of dual antiplatelet therapy (DAPT) vs. triple antiplatelet therapy in patients treated with drug-eluting stents for CAD.

Trial Scorecard: DECREASE-PCI